<?xml version="1.0" ?>
<text author="Su-Jeong Oh, Yoojin Seo, Ji-Su Ahn, Ye  Young Shin, Ji  Won Yang, Hyoung  Kyu Kim, Jin Han, Natalia  P. Mishchenko, Sergey  A. Fedoreyev, Valentin  A. Stonik, Hyung-Sik Kim" dateCollected="2019-11-03" id="autogum_academic_doc026" shortTile="echinochrome-reduces" sourceURL="https://www.mdpi.com/1660-3397/17/11/622/htm" speakerCount="0" speakerList="none" title="Echinochrome A Reduces Colitis in Mice and Induces In Vitro Generation of Regulatory Immune Cells" type="academic">
<head>
<s type="frag">
1.	LS	@ord@
Introduction	NN	introduction
</s>
</head>
<p>
<s type="decl">
Echinochrome	NNP	Echinochrome
A	DT	a
(	-LRB-	(
Ech	NNP	ech
A	DT	a
)	-RRB-	)
is	VBZ	be
a	DT	a
dark	JJ	dark
red	JJ	red
pigment	NN	pigment
separated	VBN	separate
from	IN	from
sea	NN	sea
urchin	NN	urchin
shell	NN	shell
and	CC	and
spine	NN	spine
and	CC	and
has	VBZ	have
a	DT	a
chemical	JJ	chemical
structure	NN	structure
of	IN	of
6-ethyl-2,3,5,7,8-pentahydroxy-1,4-naphthoquinone	NN	6-ethyl-2,3,5,7,8-pentahydroxy-1,4-naphthoquinone
.	.	.
</s>
<s type="decl">
As	IN	as
a	DT	a
main	JJ	main
active	JJ	active
component	NN	component
of	IN	of
a	DT	a
commercial	JJ	commercial
therapeutic	JJ	therapeutic
agent	NN	agent
called	VBD	call
‘	``	‘
histochrome	NN	histochrome
’	POS	&apos;s
,	,	,
Ech	NNP	ech
A	SYM	a
has	VBZ	have
been	VBN	be
used	VBN	use
for	IN	for
the	DT	the
treatment	NN	treatment
of	IN	of
cardiovascular	NN	cardiovascular
disorders	NNS	disorder
and	CC	and
ophthalmopathic	JJ	ophthalmopathic
complications	NNS	complication
in	IN	in
Russia	NNP	Russia
.	.	.
</s>
<s type="decl">
Among	IN	Among
the	DT	the
several	JJ	several
biological	JJ	biological
benefits	NNS	benefit
of	IN	of
Ech	NNP	ech
A	DT	a
,	,	,
anti-oxidant	JJ	anti-oxidant
and	CC	and
anti-inflammatory	JJ	anti-inflammatory
capacity	NN	capacity
is	VBZ	be
proposed	VBN	propose
as	IN	as
a	DT	a
major	JJ	major
underlying	VBG	underlie
therapeutic	JJ	therapeutic
mechanism	NN	mechanism
.	.	.
</s>
<s type="decl">
Indeed	RB	indeed
,	,	,
Ech	NNP	ech
A	SYM	a
has	VBZ	have
been	VBN	be
shown	VBN	show
to	TO	to
attenuate	VB	attenuate
the	DT	the
oxidative	JJ	oxidative
stress	NN	stress
caused	VBN	cause
by	IN	by
reactive	JJ	reactive
oxygen	NN	oxygen
species	NNS	specie
(	-LRB-	(
ROS	NNS	ROS
)	-RRB-	)
and	CC	and
cardiac	JJ	cardiac
toxic	JJ	toxic
drugs	NNS	drug
,	,	,
providing	VBG	provide
mitochondrial	NN	mitochondrial
protection	NN	protection
of	IN	of
cardiomyocyte	NN	cardiomyocyte
.	.	.
Park	NNP	Park
et	FW	et
al.	FW	al.
have	VBP	have
reported	VBN	report
similar	JJ	similar
observations	NNS	observation
showing	VBG	show
that	IN	that
Ech	NNP	ech
A	DT	a
reduced	VBN	reduce
both	DT	both
cellular	NN	cellular
and	CC	and
mitochondrial	NN	mitochondrial
ROS	NNS	ROS
levels	NNS	level
of	IN	of
patient-derived	JJ	patient-derived
cardiac	NN	cardiac
progenitors	NNS	progenitor
during	IN	during
the	DT	the
oxidative	JJ	oxidative
stress	NN	stress
situation	NN	situation
.	.	.
</s>
<s type="decl">
The	DT	the
anti-oxidative	JJ	anti-oxidative
and	CC	and
anti-viral	JJ	anti-viral
activity	NN	activity
of	IN	of
Ech	NNP	ech
A	SYM	a
has	VBZ	have
also	RB	also
been	VBN	be
proved	VBN	prove
in	IN	in
vitro	FW	vitro
using	VBG	use
a	DT	a
tick-borne	JJ	tick-borne
encephalitis	NN	encephalitis
virus	NN	virus
and	CC	and
herpes	NN	herpe
simplex	NN	simplex
virus	NN	virus
type	NN	type
1-infected	VBN	1-infected
cell	NN	cell
models	NNS	model
.	.	.
</s>
<s type="decl">
The	DT	the
therapeutic	JJ	therapeutic
potential	NN	potential
of	IN	of
Ech	NNP	ech
A	SYM	a
was	VBD	be
also	RB	also
evaluated	VBN	evaluate
in	IN	in
an	DT	an
experimental	JJ	experimental
gastric	NN	gastric
ulcer	NN	ulcer
model	NN	model
where	WRB	where
Ech	NNP	ech
A	DT	a
provided	VBN	provide
anti-ulcerogenic	JJ	anti-ulcerogenic
effects	NNS	effect
by	IN	by
increasing	VBG	increase
endogenous	JJ	endogenous
enzymatic	NN	enzymatic
and	CC	and
non-enzymatic	JJ	non-enzymatic
antioxidant	NN	antioxidant
levels	NNS	level
in	IN	in
vivo	FW	vivo
.	.	.
</s>
<s type="decl">
In	IN	in
another	DT	another
study	NN	study
,	,	,
Ech	NNP	ech
A	DT	a
treatment	NN	treatment
could	MD	could
reduce	VB	reduce
ROS	NNS	ROS
production	NN	production
and	CC	and
pro-inflammatory	JJ	pro-inflammatory
tumor	NN	tumor
necrosis	NN	necrosis
factor-α	NN	factor-α
(	-LRB-	(
TNF-α	NNP	TNF-α
)	-RRB-	)
secretion	NN	secretion
in	IN	in
a	DT	a
rat	NN	rut
model	NN	model
of	IN	of
acute	JJ	acute
uveitis	NN	uveitis
induced	VBN	induce
by	IN	by
lipopolysaccharide	JJ	lipopolysaccharide
injection	NN	injection
.	.	.
</s>
<s type="decl">
These	DT	these
previous	JJ	previous
findings	NNS	finding
imply	VBP	imply
that	IN	that
Ech	NNP	ech
A	SYM	a
could	MD	could
exert	VB	exert
a	DT	a
wide	JJ	wide
range	NN	range
of	IN	of
therapeutic	JJ	therapeutic
impacts	NNS	impact
on	IN	on
other	JJ	other
oxidative	NN	oxidative
stress-related	JJ	stress-relate
and	CC	and
inflammatory	JJ	inflammatory
pathologic	JJ	pathologic
conditions	NNS	condition
;	:	;
however	RB	however
,	,	,
the	DT	the
cell-type	JJ	cell-type
specific	JJ	specific
regulation	NN	regulation
of	IN	of
Ech	NNP	ech
A	DT	a
on	IN	on
the	DT	the
immune	JJ	immune
system	NN	system
,	,	,
which	WDT	which
consists	VBZ	consist
of	IN	of
various	JJ	various
innate	JJ	innate
and	CC	and
adaptive	JJ	adaptive
immune	NN	immune
cells	NNS	cell
,	,	,
has	VBZ	have
not	RB	not
been	VBN	be
elucidated	VBN	elucidate
yet	RB	yet
.	.	.
</s>
</p>
<p>
<s type="decl">
Inflammatory	JJ	inflammatory
bowel	NN	bowel
disease	NN	disease
(	-LRB-	(
IBD	NNP	IBD
)	-RRB-	)
is	VBZ	be
an	DT	an
intractable	JJ	intractable
,	,	,
chronic	JJ	chronic
inflammatory	JJ	inflammatory
disease	NN	disease
of	IN	of
the	DT	the
digestive	JJ	digestive
tract	NN	tract
and	CC	and
Crohn	NNP	Crohn
&apos;s	POS	&apos;s
disease	NN	disease
(	-LRB-	(
CD	NN	CD
)	-RRB-	)
and	CC	and
ulcerative	NN	ulcerative
colitis	NN	colitis
(	-LRB-	(
UC	NNP	UC
)	-RRB-	)
are	VBP	be
the	DT	the
major	JJ	major
types	NNS	type
of	IN	of
IBD	NNP	IBD
.	.	.
</s>
<s type="decl">
The	DT	the
etiology	NN	etiology
and	CC	and
pathogenic	JJ	pathogenic
mechanisms	NNS	mechanism
of	IN	of
IBD	NNP	IBD
remain	VBP	remain
largely	RB	largely
unknown	JJ	unknown
and	CC	and
both	DT	both
environmental	JJ	environmental
factors	NNS	factor
and	CC	and
genetic	JJ	genetic
factors	NNS	factor
combined	VBN	combine
with	IN	with
immunological	JJ	immunological
dysfunction	NN	dysfunction
seem	VBP	seem
to	TO	to
drive	VB	drive
IBD	NNP	IBD
development	NN	development
.	.	.
</s>
<s type="decl">
To	TO	To
attenuate	VB	attenuate
the	DT	the
excessive	JJ	excessive
immune	NN	immune
response	NN	response
,	,	,
advanced	VBN	advance
immunotherapy	NN	immunotherapy
using	VBG	use
immune-modulators	NNS	immune-modulators
such	JJ	such
as	IN	as
inflammatory	JJ	inflammatory
cytokine	NN	cytokine
blockers	NNS	blocker
has	VBZ	have
been	VBN	be
used	VBN	use
recently	RB	recently
;	:	;
however	RB	however
,	,	,
the	DT	the
presence	NN	presence
of	IN	of
non-responder	JJ	non-responder
and	CC	and
uncontrolled	JJ	uncontrolled
side	NN	side
effects	NNS	effect
are	VBP	be
the	DT	the
common	JJ	common
challenging	VBG	challenge
issues	NNS	issue
when	WRB	when
using	VBG	use
immunotherapy	NN	immunotherapy
.	.	.
</s>
<s type="decl">
Therefore	RB	therefore
,	,	,
there	EX	there
has	VBZ	have
been	VBN	be
an	DT	an
unmet	JJ	unmet
need	NN	need
to	TO	to
develop	VB	develop
novel	NN	novel
therapeutics	NNS	therapeutics
for	IN	for
the	DT	the
effective	JJ	effective
management	NN	management
of	IN	of
IBD	NNP	IBD
.	.	.
</s>
</p>
<p>
<s type="decl">
In	IN	in
this	DT	this
study	NN	study
,	,	,
we	PRP	we
investigated	VBD	investigate
whether	IN	whether
Ech	NNP	ech
A	SYM	a
could	MD	could
exhibit	VB	exhibit
a	DT	a
protective	JJ	protective
role	NN	role
in	IN	in
IBD	NNP	IBD
progression	NN	progression
using	VBG	use
a	DT	a
chemical	JJ	chemical
colitogen	NN	colitogen
dextran	NN	dextran
sodium	NN	sodium
sulfate	NN	sulfate
(	-LRB-	(
DSS)-induced	NNP	DSS)-induced
colitis	NN	colitis
mice	NNS	mice
model	NN	model
.	.	.
</s>
<s type="decl">
To	TO	To
explore	VB	explore
the	DT	the
therapeutic	JJ	therapeutic
mechanism	NN	mechanism
of	IN	of
Ech	NNP	ech
A	SYM	a
,	,	,
we	PRP	we
also	RB	also
performed	VBD	perform
in	IN	in
vitro	FW	vitro
proliferation	NN	proliferation
and	CC	and
polarization	NN	polarization
experiments	NNS	experiment
with	IN	with
two	CD	two
major	JJ	major
innate	JJ	innate
and	CC	and
adaptive	JJ	adaptive
immune	NN	immune
cells	NNS	cell
,	,	,
macrophage	NN	macrophage
and	CC	and
CD4+	NN	CD4+
helper	NN	helper
T	NN	T
cells	NNS	cell
(	-LRB-	(
Th	NNP	th
cells	NNS	cell
)	-RRB-	)
,	,	,
respectively	RB	respectively
.	.	.
</s>
<s type="decl">
Our	PRP$	our
in	IN	in
vivo	NN	vivo
findings	NNS	finding
suggest	VBP	suggest
that	IN	that
Ech	NNP	ech
A	SYM	a
could	MD	could
attenuate	VB	attenuate
the	DT	the
clinical	JJ	clinical
signs	NNS	sign
,	,	,
as	RB	as
well	RB	well
as	IN	as
histological	JJ	histological
improvement	NN	improvement
,	,	,
for	IN	for
the	DT	the
first	JJ	first
time	NN	time
in	IN	in
a	DT	a
colitis	NN	colitis
model	NN	model
which	WDT	which
represents	VBZ	represent
IBD	NNP	IBD
.	.	.
</s>
<s type="decl">
More	RBR	more
importantly	RB	importantly
,	,	,
in	IN	in
vitro	NN	vitro
results	NNS	result
demonstrate	VBP	demonstrate
that	IN	that
the	DT	the
anti-inflammatory	JJ	anti-inflammatory
function	NN	function
of	IN	of
Ech	NNP	ech
A	SYM	a
is	VBZ	be
manifested	VBN	manifested
by	IN	by
,	,	,
in	IN	in
part	NN	part
,	,	,
inducing	VBG	induce
immunomodulatory	JJ	immunomodulatory
effector	NN	effector
cells	NNS	cell
,	,	,
such	JJ	such
as	IN	as
M2	NNP	M2
macrophages	NNS	macrophage
and	CC	and
Treg	NN	Treg
cells	NNS	cell
.	.	.
</s>
</p>
</text>
